JP2022544216A5 - - Google Patents
Info
- Publication number
- JP2022544216A5 JP2022544216A5 JP2022507901A JP2022507901A JP2022544216A5 JP 2022544216 A5 JP2022544216 A5 JP 2022544216A5 JP 2022507901 A JP2022507901 A JP 2022507901A JP 2022507901 A JP2022507901 A JP 2022507901A JP 2022544216 A5 JP2022544216 A5 JP 2022544216A5
- Authority
- JP
- Japan
- Prior art keywords
- acid
- composition according
- aqueous solution
- solution composition
- aqueous
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1911461.0 | 2019-08-09 | ||
| GBGB1911461.0A GB201911461D0 (en) | 2019-08-09 | 2019-08-09 | Novel composition |
| PCT/GB2020/051900 WO2021028669A1 (en) | 2019-08-09 | 2020-08-07 | Novel composition comprising antibodies |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026066280A Division JP2026129751A (ja) | 2019-08-09 | 2026-04-14 | 抗体を含む新規組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022544216A JP2022544216A (ja) | 2022-10-17 |
| JP2022544216A5 true JP2022544216A5 (cg-RX-API-DMAC10.html) | 2023-08-15 |
Family
ID=67874470
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022507901A Pending JP2022544216A (ja) | 2019-08-09 | 2020-08-07 | 抗体を含む新規組成物 |
Country Status (11)
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019099921A2 (en) | 2017-11-17 | 2019-05-23 | Amgen Inc. | Vegfr-fc fusion protein formulations |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008543839A (ja) | 2005-06-14 | 2008-12-04 | アムジェン インコーポレーテッド | 自己緩衝タンパク質製剤 |
| US9283260B2 (en) * | 2006-04-21 | 2016-03-15 | Amgen Inc. | Lyophilized therapeutic peptibody formulations |
| GB0700523D0 (en) * | 2007-01-11 | 2007-02-21 | Insense Ltd | The Stabilisation Of Proteins |
| US8420081B2 (en) | 2007-11-30 | 2013-04-16 | Abbvie, Inc. | Antibody formulations and methods of making same |
| ES2531657T3 (es) * | 2008-05-01 | 2015-03-18 | Arecor Limited | Formulación de una proteína |
| RU2481824C2 (ru) * | 2008-10-29 | 2013-05-20 | Аблинкс Н.В | Препараты однодоменных антигенсвязывающих молекул |
| EP2598167B1 (en) * | 2010-07-30 | 2015-04-01 | Arecor Limited | Stabilized aqueous antibody compositions |
| RU2614257C2 (ru) * | 2011-04-20 | 2017-03-24 | Сандоз Аг | СТАБИЛЬНЫЕ ЖИДКИЕ ФАРМАЦЕВТИЧЕСКИЕ ПРЕПАРАТЫ СЛИТОГО БЕЛКА TNFR:Fc |
| AU2012326170B2 (en) * | 2011-10-18 | 2016-12-22 | Coherus Biosciences, Inc. | Etanercept formulations stabilized with metal ions |
| CN103358715B (zh) * | 2012-03-30 | 2016-12-14 | 山东新北洋信息技术股份有限公司 | 出纸模块的识别方法、出纸模块、打印机以及打印系统 |
| WO2014011629A1 (en) * | 2012-07-09 | 2014-01-16 | Coherus Biosciences, Inc. | Stable aqueous formulations of etanercept |
| TWI679019B (zh) * | 2013-04-29 | 2019-12-11 | 法商賽諾菲公司 | 抗ｉｌ－４／抗ｉｌ－１３之雙特異性抗體調配物 |
| WO2015080513A1 (en) * | 2013-11-29 | 2015-06-04 | Hanwha Chemical Corporation | A liquid formulation of a fusion protein comprising tnfr and fc region |
| WO2016036678A1 (en) * | 2014-09-02 | 2016-03-10 | Medimmune, Llc | Formulations of bispecific antibodies |
| KR101808234B1 (ko) * | 2015-06-23 | 2017-12-12 | (주)알테오젠 | IgG Fc 도메인을 가지는 융합 단백질의 안정한 액상 제제 |
| EP4265296A3 (en) * | 2016-09-29 | 2023-12-20 | Arecor Limited | Pharmaceutical formulation comprising an insulin compound |
| ES3064802T3 (en) * | 2016-10-21 | 2026-04-29 | Amgen Inc | Pharmaceutical formulations and methods of making the same |
| CN109937034B (zh) | 2016-11-21 | 2022-09-16 | 济世-伊沃泰克生物制品有限公司 | 阿柏西普制剂及其用途 |
| GB201703063D0 (en) * | 2017-02-24 | 2017-04-12 | Arecor Ltd | Stabilized antibody protein solutions |
-
2019
- 2019-08-09 GB GBGB1911461.0A patent/GB201911461D0/en not_active Ceased
-
2020
- 2020-08-07 CA CA3144885A patent/CA3144885A1/en active Pending
- 2020-08-07 CN CN202080056265.7A patent/CN114206391B/zh active Active
- 2020-08-07 MX MX2022001687A patent/MX2022001687A/es unknown
- 2020-08-07 IL IL290300A patent/IL290300B1/en unknown
- 2020-08-07 JP JP2022507901A patent/JP2022544216A/ja active Pending
- 2020-08-07 US US17/634,120 patent/US20220288165A1/en not_active Abandoned
- 2020-08-07 WO PCT/GB2020/051900 patent/WO2021028669A1/en not_active Ceased
- 2020-08-07 KR KR1020227006365A patent/KR20220044761A/ko active Pending
- 2020-08-07 EP EP20753794.5A patent/EP4010365A1/en active Pending
- 2020-08-07 AU AU2020328218A patent/AU2020328218A1/en active Pending
- 2020-08-07 CN CN202610059484.XA patent/CN121910662A/zh active Pending
- 2020-08-07 CN CN202610072854.3A patent/CN121926875A/zh active Pending
-
2025
- 2025-11-20 US US19/395,382 patent/US20260077016A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Cross et al. | N-terminal deletions in Rous sarcoma virus p60 src: effects on tyrosine kinase and biological activities and on recombination in tissue culture with the cellular src gene | |
| JP2024160287A (ja) | ＶＥＧＦＲ－Ｆｃ融合タンパク質製剤 | |
| WO2011141926A2 (en) | Liquid formulation of polypeptides containing an fc domain of an immunoglobulin | |
| TW201325607A (zh) | 用胺基酸穩定化之依那西普調配物 | |
| CN107596358A (zh) | 艾杜糖‑2‑硫酸酯酶的纯化 | |
| Janciauskiene et al. | Differential detection of PAS‐positive inclusions formed by the Z, Siiyama, and Mmalton variants of α1‐antitrypsin | |
| KR20200102432A (ko) | 신규 조성물 | |
| JP2016520646A (ja) | Ｇｃ−マクロファージ活性化因子を含む組成物およびその使用 | |
| US20130183330A1 (en) | Recombinant avian infectious coryza vaccine and process for preparing same | |
| CN102482341A (zh) | 纯化vwf以增加非-脂质包封的病毒的去除 | |
| JP2019510741A5 (cg-RX-API-DMAC10.html) | ||
| JP2024507347A5 (cg-RX-API-DMAC10.html) | ||
| WO2023164898A1 (zh) | 一种重组融合蛋白的制剂 | |
| WO2021050585A1 (en) | Compositions, methods, and kits for detection of lipolytic activity | |
| RU2022105796A (ru) | Новая композиция, содержащая антитела | |
| CN114206391B (zh) | 包含抗体的新组合物 | |
| JP6383721B2 (ja) | 創傷治癒剤 | |
| TW201713311A (zh) | 那他珠單抗的穩定水性調配物 | |
| JP2024506718A5 (cg-RX-API-DMAC10.html) | ||
| Hu et al. | Functional significance of alternate phosphorylation in Sendai virus P protein | |
| US20220265782A1 (en) | Stabilizing therapeutic proteins with piperazin- or morpholine-containing zwitterionic buffering substances | |
| JP2024506718A (ja) | 工学作成二量体タンパク質の安定性を高めるための水溶液組成物 | |
| US20190231847A1 (en) | Treatment of ocular disease | |
| TW202528339A (zh) | 用於治療或預防肝臟病症之骨髓源性生長因子 | |
| RU2395582C2 (ru) | СПОСОБ РАСЩЕПЛЕНИЯ ПОЛИПЕПТИДОВ С ИСПОЛЬЗОВАНИЕМ ВАРИАНТА ПРОТЕАЗЫ ОmpТ |